VOYA Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-29,670
Closed -$1.18M 2496
2026
Q1
$1.18M Hold
29,670
﹤0.01% 1409
2025
Q4
$742K Hold
29,670
﹤0.01% 1592
2025
Q3
$719K Hold
29,670
﹤0.01% 1599
2025
Q2
$390K Hold
29,670
﹤0.01% 2002
2025
Q1
$427K Hold
29,670
﹤0.01% 1947
2024
Q4
$497K Buy
+29,670
New +$491K ﹤0.01% 1938

VOYA Investment Management's CNTA Position: Q2 2026 in Review

VOYA Investment Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 29,670 shares — an estimated $1.18M sold.

VOYA Investment Management first reported a position in CNTA in Q4 2024 and held it in 6 quarters. The position peaked at $1.18M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

  • VOYA Investment Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • VOYA Investment Management sold 29,670 Centessa Pharmaceuticals shares in Q2 2026, an estimated $1.18M.
  • VOYA Investment Management first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 6 quarters.
  • VOYA Investment Management's Centessa Pharmaceuticals position peaked at $1.18M in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.